Newsfeeds - Spark Newswire

3 minute read

World Class Leaders In Psychedelics Form Benzinga’s Psychedelic Advisory Council—Get To Know Them

Today, 5:42 AM

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.

ATAI

7 minute read

Psyched: Big Pharma’s Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved

By Natan Ponieman

Today, 5:42 AM

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education.

ATAI

2 minute read

NeonMind To Improve Patient Care And Data Management With Thrive Health’s Digital Healthcare Platform

By Vuk Zdinjak

Today, 5:42 AM

NeonMind Biosciences Inc.

CSE:NEON

2 minute read

NeonMind To Launch 10 Mental Health Clinics In Canada, How Will Patients Benefit?

By Jelena Martinovic

Today, 5:42 AM

NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript Solutions, leading Canadian specialty healthcare services and medical treatment providers.

CSE:NEON

2 minute read

NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss

By Vuk Zdinjak

Today, 5:42 AM

NeonMind Biosciences Inc. (OTCQB:NMDBF) (CSE:NEON) (FRA:6UF) has filed a new patent application with the U.S. Patent and Trademark…

CSE:NEON

3 minute read

Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial

By Natan Ponieman

Today, 5:42 AM

A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials,…

NMDBF

2 minute read

NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division

By Vuk Zdinjak

Today, 5:42 AM

NeonMind Biosciences Inc. (OTCQB:NMDBF) (CSE:NEON) (FRA:6UF) provided a summary of business highlights on the company’s activities and progress across…

CSE:NEON

4 minute read

Psyched: First Australian Psych Company On Nasdaq, Utah’s Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results

By Natan Ponieman

Today, 5:42 AM

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of…

CSE:LUV

3 minute read

Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified

By Jelena Martinovic

Today, 5:42 AM

Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed Ana Bowman as a chief financial officer, effective February 22.

CSE:MMEN

2 minute read

Benzinga’s Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th

By Benzinga Cannabis

Today, 5:42 AM

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022, in Miami, Florida.

CSE:ENBI